- Home
- ITIC vs ETON Comparison
ITIC vs ETON Comparison
Compare ITIC & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITIC
- ETON
- Stock Information
- Founded
- ITIC 1972
- ETON 2017
- Country
- ITIC United States
- ETON United States
- Employees
- ITIC N/A
- ETON N/A
- Industry
- ITIC Specialty Insurers
- ETON Biotechnology: Pharmaceutical Preparations
- Sector
- ITIC Finance
- ETON Health Care
- Exchange
- ITIC Nasdaq
- ETON Nasdaq
- Market Cap
- ITIC 437.8M
- ETON 428.5M
- IPO Year
- ITIC N/A
- ETON 2018
- Fundamental
- Price
- ITIC $240.98
- ETON $17.22
- Analyst Decision
- ITIC
- ETON Strong Buy
- Analyst Count
- ITIC 0
- ETON 3
- Target Price
- ITIC N/A
- ETON $27.67
- AVG Volume (30 Days)
- ITIC 14.0K
- ETON 231.3K
- Earning Date
- ITIC 05-08-2025
- ETON 05-13-2025
- Dividend Yield
- ITIC 6.44%
- ETON N/A
- EPS Growth
- ITIC 18.56
- ETON N/A
- EPS
- ITIC 15.69
- ETON N/A
- Revenue
- ITIC $261,183,000.00
- ETON $39,011,000.00
- Revenue This Year
- ITIC N/A
- ETON $92.33
- Revenue Next Year
- ITIC N/A
- ETON $54.19
- P/E Ratio
- ITIC $15.37
- ETON N/A
- Revenue Growth
- ITIC 15.26
- ETON 23.29
- 52 Week Low
- ITIC $146.41
- ETON $3.18
- 52 Week High
- ITIC $290.40
- ETON $18.41
- Technical
- Relative Strength Index (RSI)
- ITIC 57.98
- ETON 73.49
- Support Level
- ITIC $234.99
- ETON $16.43
- Resistance Level
- ITIC $245.00
- ETON $17.74
- Average True Range (ATR)
- ITIC 4.54
- ETON 1.09
- MACD
- ITIC 1.09
- ETON 0.16
- Stochastic Oscillator
- ITIC 84.20
- ETON 65.01
About ITIC Investors Title Company
Investors Title Co operates in the title insurance and exchange services sectors. The title insurance segment, conducted through ITIC and NITIC, offers title insurance policies for residential, commercial, and industrial properties in around 22 states and the District of Columbia, with a focus on the eastern United States. The title insurance segment issues title insurance policies through approved attorneys from underwriting offices and through independent issuing agents. Title insurance policies insure titles to real estate.n The Title Insurance segment contributes the majority of the company's revenue.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.